Mnohočetný myelom a další
monoklonální gamapatie




A randomised phase 3 trial of thalidomide and prednisone as maintenance therapy after ASCT in patients with MM with a duality-of-life assesment: the National Cancer Institute od Canada Clinical Trials Group Myeloma 10 Trial

Otevřít | 2013 | prof. MUDr. Zdeněk Adam, CSc.

First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial

Otevřít | 2010 | MUDr. Jana Gombošová

Monoclonal gammapathy of undetermined significance: a consensus statement

Otevřít | 2010 | MUDr. Marie Langová

Melphalan 200 mg/m2 versus melphalan 100 mg/m2 in newly diagnosed myeloma patients: a prospective, multicenter phase 3 study

Otevřít | 2010 | MUDr. Petr Szturz

A randomized phase 3 study on the effect of thalidomide combined with adriamycin, dexamethasone, and high-dose melphalan, followed by thalidomide maintenance in patients with multiple myeloma

Otevřít | 2010 | MUDr. Petr Szturz

VMP (bortezomib, melphalan, and prednisone) is active and well tolerated in newly diagnosed patients with multiple myeloma with moderately impaired renal function, and results in reversal of renal impairment: cohort analysis of the phase III VISTA study

Otevřít | 2009 | MUDr. Petr Szturz

International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple myeloma

Otevřít | 2009 | MUDr. Petr Szturz

Single autologous stem-cell transplantation followed by maintenance therapy with thalidomide is superior to double autologous transplantation in multiple myeloma: results of a multicenter randomized clinical trial

Otevřít | 2008 | MUDr. František Folber

Lenalidomide plus dexametasone for relapsed or refractory multiple myeloma

Otevřít | 2008 | MUDr. František Folber

Multicenter, randomized, double-blind, placebo-controlled study of thalidomide plus dexametasone compared with dexametasone as initial therapy for newly diagnosed multiple myeloma

Otevřít | 2008 | MUDr. František Folber

Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma

Otevřít | 2008 | MUDr. František Folber

High-dose melphalan versus melphalan plus dexamethasone for AL amyloidosis

Otevřít | 2008 | MUDr. František Folber

Lenalidomide plus dexamethasone for relapsed multiple myeloma in North America

Otevřít | 2008 | MUDr. František Folber

Randomized phase III study of pegylated liposomal doxorubicin plus bortezomib compared with bortezomib alone in relapsed or refractory multiple myeloma: combination therapy improves time to progression

Otevřít | 2008 | MUDr. František Folber

Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma

Otevřít | 2008 | MUDr. František Folber

Clinicopathological definition of Waldenström´s macroglobulinaemia: Consensus Panel Recommendation from the Second International Workshop on Waldenström´s macroglobulinemia.

Otevřít | 2008 | Prof. MUDr. Zdeněk Adam, CSc.

Plasma exchange when myeloma presents as acute renal failure

Otevřít | 2008 | Prof. MUDr. Zdeněk Adam, CSc.

Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomized controlled trial

spojeno s:


Superiority of melphalane prednisone (MP) + thalidomid over MP and autologous stem cell transplantation in the treatment of newly diagnose elderly patients with multiple myeloma

Otevřít | 2006 | Prof. MUDr. Zdeněk Adam, CSc.
cheap jerseys list cheap jerseys online outlet for sale MLB Jerseys,NHL Jerseys store,NBA Jerseys,Soccer Jerseys,NCAA Jerseys